Background: Although recent meta-analyses indicates a consistent significant inverse relation of serum 25 (OH) D and the prevalence of gestational diabetes mellitus (GDM), the mechanism is unclear and conflicting opinions continue to be reported. Objectives: The objectives are: 1) comparison of vitamin D status in diabetic and non-diabetic pregnant women; 2) trying to determine the level of vitamin D associated with GDM, and its sensitivity and specificity; 3) determination of the relation of hypovitaminosis D with insulin resistance. Subjects and Methods: One hundred consecutive pregnant women (<28 weeks gestational period) from the attendants of the out-patient clinic at our hospital were diagnosed for GDM by glucose tolerance test (GTT) (75 g 2 h). Among them, 40 patients met the inclusion criteria for this study (group I). As a comparative group, another 40 pregnant ladies were included, 20 of them (group II) had pre-gestational type II DM, and the other 20 (group III) had normal glucose tolerance (NGT) as a control. For all the participants, we estimated fasting blood glucose, fasting serum insulin, homeostasis model assessment of (HOMA-IR and HOMA-B) , quantitative insulin sensitivity check index (QUICKI), and serum 25-OH vit D. The ROC curve analysis was used to determine the optimal threshold value of vit D in relation to DM. Results: Compared to the control group, the diabetic patients showed a statistically significant increase in the levels of fasting glucose, 1-hour postprandial glucose, 2-hour post prandial glucose, fasting insulin, and HOMA-IR, (P=0.000 for all). None of the diabetic patients showed optimal vit D level. Vit D insuficiency (10 -29 ng/ml) was found in 32.5% of patients in group I, 55% in group II, and 50% in group III. Vit D deficiency (<10 ng/ml) was found in 67.5% of patients in group I, 45% in group II, and 0% in group III. Significant negative correlation was found for vit D with fasting insulin and FBS. The AUC for 25 OH vit D was 97%, CI was 95% and p-value was 0.0001. The sensitivity, specificity, and positive and negative predictive values of 25 OH vit D in GDM versus control persons were 97%, 90%, 95.1%, 94.7% respectively at a cut-off level <22 ng/ml. Conclusions: Although it might seem premature to draw a sharp relation between hypovi-G. M. taminosis D and GDM, this study showed the importance of vit D in GDM, the need for supplementation below 22 ng/ml, and the role of hypovitaminosis D in increasing insulin resistance. Further randomized studies with vit D supplementation are recommended.
Introduction
Although, recent evidence suggests that vitamin D deficiency may contribute to the development of type II diabetes mellitus (T2DM), the exact mechanism is unknown [1] [2] . The prevalence of GDM is increasing, reached almost 15% -20% [3] . Unmanaged gestational diabetes increases the risk of developing T2DM after pregnancy and predisposes the offspring to childhood obesity and T2DM later in life [4] . Compelling evidence suggests a role of vitamin D deficiency in the pathogenesis of insulin resistance and insulin secretion derangements. The coexistence of insulin resistance and vitamin D deficiency has generated several hypotheses as worsening insulin resistance [5] . Immense interest persists in vitamin D and its potential effects on several pregnancy outcomes including gestational diabetes mellitus (GDM) [6] . Although vitamin D deficiency during pregnancy reached 40% -100% in some countries, no similar studies about Egyptian females were done [7] - [11] .
Vitamin D deficiency appears to be associated with altered glucose homeostasis during pregnancy [12] [13] . Although [1.25 (OH) D] supplementation was reported to decrease glucose and increase insulin levels [14] , other studies found no significant differences in vitamin D status between women with GDM and NGT [15] [16] . Emerging evidence suggests that vitamin D administration can improve insulin sensitivity and glucose tolerance, but whether vitamin D supplementation can prevent GDM is unknown [17] . Although, vitamin D deficiency is associated with a higher risk of GDM, conflicting evidence is provided as to whether low serum 25-hydroxyvitmain D (25 (OH) D) levels are associated with GDM. Therefore, we conducted this study for: -Comparison of vit D status in pregnant women; -Trying to determine the level of vitamin D associated with GDM, and its sensitivity and specificity; -Determination of the relation of hypovitaminosis D with insulin resistance.
Material and Methods
After approval of the local health ethical committee and a written consent, we conducted an observational case control study on pregnant women attending the out-patient clinic at our hospital between September 2013 to September 2015. The inclusion criteria were pregnant ladies <28 weeks gestational age. The exclusion criteria included previous history of GDM or obstetric complications, metabolic bone disease, abnormal liver function, impaired kidney function, or patients receiving medication known to affect calcium & vit D metabolism (except routine prenatal vitamin supplements including calcium). One hundred consecutive pregnant women with GDM were studied. From them, only 40 patients met the inclusion criteria for this study (group I). As a comparative group, another 40 pregnant ladies were included, 20 of them (group II) had pre-gestational type II DM, and the other 20 (group III) had normal glucose tolerance (NGT) as a control. The glucose tolerance test (GTT) (75 g 2 h) was used to diagnose GDM according to the guidelines of the international association of diabetes and pregnancy study groups (IADPSG) 2010. The diagnosis was confirmed when the plasma glucose level exceeded: fasting: ≥92 mg/dL (5.1 mmol/L), 1 h: ≥180 mg/dL (10.0 mmol/L), 2 h: ≥153 mg/dL (8.5 mmol/L).
All the participants were subjected to: -Full history taking including gestational age, history of previous GDM, family history of diabetes and history of maternal and neonatal complications; -Thorough clinical examination including assessment of blood pressure, calculation of the body mass index (BMI), and obesity was defined as BMI >30 kg/m and morbid obesity >40 
Statistical Analysis
Data was collected and included in a data based system and analyzed by statistical package of social sciences ((SPSS, Inc., Chicago, IL, USA)) version 17. Parametric data were expressed as mean ± standard deviation (SD). It was analyzed statistically using student t-test while non-parametric data were expressed as percentages and were analyzed using chi square. The Pearson correlation coefficients (r) were used to study the correlation between different parametric variables. Spearman correlation coefficients were used to study the correlation with non-parametric variables. Logistic regression analysis was done to calculate the odds ratio to determine the contribution of some variables to gestational diabetes. Receiver operating characteristics (ROC) analysis was used to identify the optimal threshold values of 25 OH vitamin D. Sensitivity and specificity, positive and negative predictive values of 25 (OH) vitamin D were profiled by curves. Table 1 shows the demographic and clinical, biochemical characteristics among the study groups and their statistical significance. There was a significant increase in systolic and diastolic blood pressure (P = 0.00, 0.05), BMI, family history of diabetes, (P < 0.5) noticed in comparing the diabetic groups (gestational and pre gestational) in relation to control group. A statistically significant increase was detected in FBS, 1-H glucose, 2-H glucose, fasting insulin, (HOMA-IR), HbA1c, (P = 0.00). A statistically significant decrease in vitamin D serum level and in diabetic groups compared to control group (P = 0.00), A significant decrease in total and ionized calcium and QUICKI in diabetic groups compared to control group (P = 0.00). Table 2 and Figure 1 show that no patient in the diabetic groups has the optimal vitamin D level. Insufficient vitamin D levels were found in 32.5% of GDM, 55% of diabetic and 50% of control group (10 -29 ng/ml). Sever form of vitamin D deficiency in 67.5% of GDM and 45% of diabetic group (P = 0.00). 50% of control group has optimal level.
Results
In the GDM group, serum 25 (OH) vit D had a significant negative correlation with BMI, fasting insulin (P = 0.00, 0.05 respectively), and tendency towards significant positive correlation with HOMA-B (P = 0.09). In the diabetic group; serum 25 (OH) vit D had a highly significant negative correlation with CRP (P = 0.00) ( Table 3 & Figure 2 ). HOMA-IR has a positive correlation with FBS in both diabetic groups (P = 0.05, 0.01 respectively), a positive correlation with 2-H glucose in GDM, (P = 0.03) ( Table 4 ). The relative risk for developing GDM was higher with increasing systolic and diastolic blood pressure, triglycerides, total cholesterol, low density lipoprotein, body mass index and C-reactive protein with odds ratio (1.07, 1.06, 1.04, 1.21, 1.17, 1.93 and 1.04 respectively) (P = 0.00, 0.02, 0.01) and confidence interval 95%. When all patients with GDM were evaluated, the AUC for 25 OH vitamin D was (0.97), CI was (0.95%), and p-value = 0.0001 (Figure 3) . The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 25 OH vitamin D levels in GDM patients relative to the control group were 97.5%, 90%, 95.1%, and 94.7% respectively) at a cut-off value of ≤ 22 ng/ml ( Table 5 ).
Discussion
The main limitations for this study included the small number of patients and absence of evaluation for the effect of vit D supplementation. Controversy still exists about the exact role of vit. D deficiency in the pathogenesis of DM, especially, GDM. Many previous studies [18] [19] reported high prevalence of vitamin D deficiency that reached approximately 95% among both pregnant and non-pregnant women. Even in the sunny-Egypt, we also found high prevalence of vitamin D deficiency especially during pregnancy. This may be explained by poor sun exposure, poor dietary intake, and lack of physical activity.
Race/ethnicity is an important determinant of vitamin D deficiency. Yu et al. [20] studied 180 pregnant women of four ethnic groups and compared their serum 25-hydroxyvitamin D at gestational week 27. They Odds ratio, BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure. TG = triglycerides, T-Chol = total cholesterol, HDL-Chol = high density lipoprotein cholesterol, LDL-Chol = low density lipoprotein cholesterol. high prevalence (72%) of vitamin D deficiency among Saudi women of childbearing age. Vit D deficiency may predispose to glucose intolerance, altered insulin secretion and type 2 diabetes [22] - [24] either directly via vit D receptor (VDR) activation, indirectly via calcemic hormones, or via inflammation [25] . The presence of VDR in the pancreatic В cells suggests an endocrine role of vitamin D in GDM may be through augmenting insulin secretion and insulin sensitivity [26] .
In concordance with several cross-sectional studies, the present study reported an association between low maternal vitamin D status and GDM. Group I and II have low serum vitamin D levels in comparison with control with more deficiency in GDM group. The mean levels were 8.8, 10.8 and 30.9 ng/ml respectively). A cutoff point for vit D serum level in prediction of GDM was determined by application of receiver operating characteristic (ROC) curve. It was found to be at a level of 22 ng/ml with a sensitivity of 97.5% and a specificity of 90% (P = 0.00).
There is a complex relationship between vitamin D and obesity. While our and other many studies [27] - [34] reported an inverse relation between vit D levels and BMI to the extent of considering it as a strong predictor of vit D [27] [28] [33] little studies found no significant association between vitamin D and BMI [35] [36] .
Some authors [37] [38] reported that alteration of the vitamin D in obese subjects is characterized by secondary hyperparathyroidism which may be associated with enhanced renal tubular reabsorption of calcium and increased circulating 1.25 (OH)2D which may cause a feedback inhibition of 25 (OH) D synthesis. This feedback was a matter of doubt in other studies [39] [40] . We agree with Torloni et al. [41] in that the risk of GDM is positively associated with pre pregnancy BMI. We found an inverse association between serum 25OHD and BMI in patients with GDM (P = 0.00). The logistic regression analysis (LRA) revealed that the risk of GDM increases by 1.93 times more with increase BMI.
In agreement with Farrant et al. [42] , the present study showed no association between vitamin D serum level and HbA1c. Despite this, other studies [43] - [45] showed a potential interaction between 25 (OH) D and blood glucose control in pregnancy.
In agreement with [46] , we found that vitamin D had significant negative association with fasting insulin (P = [50] revealed that 25OHD levels in non-pregnant women were positive correlated with insulin sensitivity and that higher 25OHD levels were associated with a lower risk of IGT and T2DM. They concluded a positive correlation between 25OHD levels and insulin sensitivity. This may be explained by the importance of vit D for helping β-cells of the pancreas to keep up with growing insulin demand. Also, it helps the parafollicular cells of the thyroid gland to produce calcitonin, the hormone that moves calcium into the tissues. Calcitonin triggers the release of insulin from the β-cell "pockets" in which it is stored, keeping up with the greater demand for insulin by mother and developing child [51] . The placenta has a capacity to synthesize active 1, 25 (OH)2 D which is linked to the immune-modulatory function of the placenta in humans [52] .
Maghbooli et al. [35] investigated the relationship between serum 25-OH vit D and insulin resistance, using the HOMA equation. They found increased vit D deficiency in the GDM group than in the IGT and normal groups (44%, 33%, and 23%, respectively). Daniel and Keller [53] reported that lower levels of 25OHD were associated with an increased risk of GDM by 40% for each one standard deviation (SD) decrease in 25 OH Vit D level (odds ratio, 1.40/1 SD) [95% CI, P = 0.04]. In the present study, we could not document any association between hypovitaminosis D and HOMA-IR. This may be explained by the different ethnicity or the small-sized study sample. Ethnicity was considered as a risk factor for altered vitamin D status and may independently affect the association between 25OHD levels and the risk of diabetes [18] . Clifton-Bligh et al. [54] reported that serum 25-hydroxyvitamin D was negatively correlated with fasting plasma glucose, fasting insulin, and insulin resistance (calculated by HOMA-IR) which was statistically insignificant. Maghbooli et al. [35] who found that HOMA-IR ≥3 (indicative of insulin resistance) in those with vitamin D deficiency more than in those with normal vitamin D. Also, Wang et al. [44] reported that low vitamin D levels were associated with increased the risk of GDM and high serum 25OHD levels were associated with reduced risk of insulin resistance. After adjusting for ethnicity, age and BMI, Joergensen et al. [45] reported inverse correlation between 25 (OH) D and fasting glucose, insulin and HOMA-IR index. The relationship with glucose retained borderline significance.
In the Third National Health and Nutrition Examination Survey (NHANES III) and a meta-analysis of crosssectional studies, serum 25OHD levels were found to be inversely associated with the risk of diabetes in nonHispanic whites and Mexican Americans, but not in non-Hispanic blacks [22] [50] .
Borissova et al. [55] evaluated the effects of vitamin D3 supplementation on insulin secretion and insulin resistance in 10 women with T2DM. Administration of 1332 IU/day cholecalciferol for 1 month significantly increased plasma 25OHD levels and increased first-phase insulin secretion during an intravenous glucose tolerance test.
In agreement with Pradhan et al. [56] , the present study supports the inflammatory role in pathogenesis of type 2 DM as we found a significant increase in C-reactive protein (CRP) in the patient groups (gestational and pre gestational) in comparison to the control group (P = 0.00). Gregor and Hotamisligil [57] reported that insulin binding to its receptor triggers tyrosine phosphorylation of insulin receptor substrates (IRS). Inflammatory signals can target IRS-1 for serine phosphorylation, which inhibits the insulin receptor signaling cascade [58] . In the present study, there was an inverse correlation between hypovitaminosis D and CRP as an inflammatory marker in the diabetic groups (P = 0.00) as vit D played an important role in the modulation of inflammatory response. Also, some cross-sectional studies indicate that hypovitaminosis D is associated with higher serum levels of inflammatory biomarkers, such as CRP in healthy [59] , and in obese subjects [60] . But, this could not be confirmed these findings [33] [61].
Conclusion
Although it might seem premature to draw a sharp relation between hypovitaminosis D and GDM, this study showed the importance of vit D in GDM, the need for supplementation below 22 ng/ml, and the role of hypovitaminosis D in increasing insulin resistance. Further randomized studies with vit D supplementation are recommended.
